Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: musculoskeletal disease

Advocacy and More

David A. Fox, MD  |  April 1, 2008

A week in the life of the ACR

Filed under:Legislation & AdvocacyPresident's PerspectiveProfessional Topics Tagged with:AC&RAdvocates for ArthritisCapitol HillCongressLegislationPolitics

Envision Arthritis Pathology

Philip G. Conaghan, MB BS, PhD  |  April 1, 2008

MRI advances in RA and OA

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Magnetic resonance imaging (MRI)MRIosteoarthritis (OA)PatheogenesisRheumatoid Arthritis (RA)

Giant Cell Arteritis

Staff  |  March 1, 2008

Giant cell arteritis (GCA)—a type of vasculitis—is a group of diseases whose typical feature is inflammation of blood vessels. The blood vessels most commonly involved are the arteries of the scalp and head (especially the arteries over the temples), which is why another term for GCA is “temporal arteritis.” GCA can overlap with another rheumatic disease called polymyalgia rheumatica, and symptoms of the two conditions can occur at the same time or separately. The causes of GCA and polymyalgia rheumatica are unknown.

Filed under:ConditionsFrom the College Tagged with:Diagnostic CriteriaGiant Cell ArteritisTreatment

Rheumatology’s Divergent Thinkers

Gretchen Henkel  |  February 1, 2008

OMERACT selects outcomes measures with an egalitarian process

Filed under:Meeting ReportsPractice Support Tagged with:clinical trialsInternationalmeasuresOMERACTOutcome Measures in RheumatologyOutcomes

In Memoriam: John Bland, MD

Paul Plotz, MD  |  February 1, 2008

John Hardesty Bland, MD, professor of medicine emeritus at the University of Vermont College of Medicine in Burlington, died on March 15, 2007. He was midway through his 90th year, fulfilling the prescription of his last book, Live Long, Die Fast: Playing the Aging Game to Win, published when he was 80. A consummate rheumatologist and wonderful bedside doctor and teacher, Dr. Bland was also one of the genuine polymaths in the American medical world.

Filed under:Profiles Tagged with:In Memoriam

Increase NIH Funding, Participate in Advocates for Arthritis

Staff  |  January 1, 2008

The ACR consistently urges Congress to support issues relating to rheumatologists, rheumatology health professionals, and patients. The primary advocacy goals are: supporting of the “Arthritis Prevention, Control, and Cure Act of 2007” (H.R.1283/S.626) and the “Access to Medicare Imaging Act of 2007” (H.R.1293/S.1338), finding a permanent solution to the Medicare reimbursement issue, and increasing funding for the National Institutes of Health (NIH)—including the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Allergy and Infectious Diseases—and other agencies, such as the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, the Department of Veterans Affairs’ Medical and Prosthetic Research Program.

Filed under:From the CollegeLegislation & AdvocacyResearch Rheum Tagged with:AdvocacyCDCClinical researchNational Institutes of HealthNIHResearchRheumatoid arthritis

European Beacon for Rheumatology

Gretchen Henkel  |  January 1, 2008

Josef S. Smolen, MD, led the way for outcomes measures and a scientifically based training program

Filed under:Practice SupportProfessional TopicsProfiles Tagged with:CareerImmunologyMetricsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)rheumatologyTraining

Rehabilitation and Myositis

Michael O. Harris-Love, DSc, MPT  |  January 1, 2008

Physical therapy to manage inflammatory muscle disease

Filed under:ConditionsMyositis Tagged with:Exercise/physical therapymyositisPatientsTreatment

ARHP in 2008

Kimberly Kimpton, PT  |  December 1, 2007

As I begin my presidency, let me thank you—the ARHP membership—for allowing me to steer this organization through the 2008 year. As a physical therapist in clinical practice for more than 25 years, I have experienced the challenges of treating people with arthritis and rheumatic diseases. For the past 13 years, I have served the ARHP in various capacities and, as my personal involvement in the ARHP has grown, my knowledge of this premier rheumatology organization has also expanded.

Filed under:From the CollegeResearch Rheum Tagged with:Association of Rheumatology Professionals (ARP)EducationResearch

Is Your Office Lab Up to Par?

Staff  |  December 1, 2007

Rheumatology practices with laboratory testing facilities in their offices can offer important benefits to patients and physicians. During their care of patients with musculoskeletal and rheumatic diseases, rheumatologists may order many tests, including erythrocyte sedimentation rate, synovial fluid analysis, complete blood count, fecal occult test, and urinalysis. While the prompt receipt of test results and the capability to evaluate specimens in the office directly improves efficiency, it is important to remember that offices must be certified to perform laboratory testing, particularly high-complexity tests such as the analysis of synovial fluids.

Filed under:From the CollegeGout and Crystalline ArthritisPractice Support Tagged with:laboratory testsPractice Managementsynovial fluid

  • « Previous Page
  • 1
  • …
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences